Omni-Protech Drugs Private Limited

Pharmaceutical contract manufacturing of various capsules, syrup, and liquid medications.

1993 | Pune, Maharashtra (India) | Active
Last Updated:

Omni-Protech Drugs Profile

Key Indicators

  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 4.50 M
  • Company Age 31 Year, 11 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 31.65 Cr
  • Satisfied Charges ₹ 11.20 Cr
  • Revenue Growth -17.38%
  • Profit Growth -43.62%
  • Ebitda -48.43%
  • Net Worth 9.12%
  • Total Assets -6.64%

About Omni-Protech Drugs

Omni-Protech Drugs Private Limited (ODPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 March 1993 and has a history of 31 years and 11 months. Its registered office is in Pune, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.50 M.

The company currently has active open charges totaling ₹31.65 Cr. The company has closed loans amounting to ₹11.20 Cr, as per Ministry of Corporate Affairs (MCA) records.

Brijmohan Sharma, Bipin Katdare, and Atharva Sharma serve as directors at the Company.

Company Details

  • Location

    Pune, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    omniprotech.in

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24239PN1993PTC071120

  • Company No.

    071120

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    12 Mar 1993

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Pune

Industry

Pharma

Who are the key members and board of directors at Omni-Protech Drugs?

Board Members (3)

NameDesignationAppointment DateStatus
Brijmohan Sharma Country flag representing In Director 20-Jul-2003Current
Bipin Katdare Country flag representing In Whole-Time Director 30-Dec-2008Current
Atharva Sharma Country flag representing In Director 09-Jun-2021Current

Financial Performance of Omni-Protech Drugs.

Omni-Protech Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.38% decrease. The company also saw a substantial fall in profitability, with a 43.62% decrease in profit. The company's net worth moved up by a moderate rise of 9.12%.

Omni-Protech Drugs revenue growth over time
Omni-Protech Drugs profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-17.38%
Revenue from Operations
-19.50%
Total Assets
-6.64%
Profit or Loss
-43.62%
Net Worth
9.12%
EBITDA
-48.43%

What is the Ownership and Shareholding Structure of Omni-Protech Drugs?

In 2023, Omni-Protech Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹316.47 M

Satisfied Charges

₹112.00 M

Charges Breakdown by Lending Institutions

  • Axis Bank Limited : 20.15 Cr
  • Bnp Paribas : 9.50 Cr
  • Hdfc Bank Limited : 2.00 Cr

Latest Charge Details

DateLenderAmountStatus
04 Jun 2024Axis Bank Limited₹20.15 CrOpen
23 Feb 2024Hdfc Bank Limited₹2.00 CrOpen
14 Aug 1997Bnp Paribas₹9.50 CrOpen
23 Mar 2009Bank Of Maharashtra₹4.50 CrSatisfied
11 Nov 2003Bank Of Maharashtra₹1.00 CrSatisfied

How Many Employees Work at Omni-Protech Drugs?

Omni-Protech Drugs has a workforce of 84 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Omni-Protech Drugs Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Omni-Protech Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omni-Protech Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Omni-Protech Drugs

Recent activity within the organization

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 201.47 M with Charge ID 100949737 was registered on 04 Jun 2024.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 20.00 M with Charge ID 100886251 was registered on 23 Feb 2024.

  • Annual General Meeting

    Omni-Protech Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Omni-Protech Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Pune.

  • Charges

    A charge registered on 11 Nov 2003 via Charge ID 90086577 with Bank Of Maharashtra was fully satisfied on 18 Jun 2021.

  • Director Appointment

    Atharva Brijmohan Sharma was appointed as a Director was appointed as a Director on 09 Jun 2021 & has been associated with this company since 3 years 8 months .

Frequently asked questions

  • What is the Incorporation or founding date of Omni-Protech Drugs Private Limited?

    Omni-Protech Drugs Private Limited was incorporated on 12 Mar 1993.

  • What is authorized share capital and paid-up capital of Omni-Protech Drugs Private Limited?

    The authorized share capital of Omni-Protech Drugs Private Limited is ₹ 5.00 M and paid-up capital is ₹ 4.50 M.

  • Who are the current board members & directors of Omni-Protech Drugs Private Limited?

    Currently 3 directors are associated with Omni-Protech Drugs Private Limited.

    • Brijmohan Sharma
    • Bipin Vasantrao Katdare
    • Atharva Brijmohan Sharma

  • What is the registered address of Omni-Protech Drugs Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Omni-Protech Drugs Private Limited is Plot No.C-4-13 Midc Functionalelectronics Indl.Estate Bhosar I India, Pune, Maharashtra, 411026.

  • What is the corporate identification number (CIN) and company number of Omni-Protech Drugs Private Limited?

    The corporate identification number (CIN) of Omni-Protech Drugs Private Limited is U24239PN1993PTC071120 and the company number is 071120 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Omni-Protech Drugs Private Limited?

    The Official website of Omni-Protech Drugs Private Limited is https://www.omniprotech.in

  • What has been the recent revenue trend for Omni-Protech Drugs Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Omni-Protech Drugs Private Limited has fallen by -17.38%.

  • How many employees does Omni-Protech Drugs Private Limited currently have?

    As Per 2023 financial reports, 84 employees are currently employed by Omni-Protech Drugs Private Limited.

  • What change has been observed in the net worth of Omni-Protech Drugs Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Omni-Protech Drugs Private Limited has experienced an upsurge of 9.12%.

  • What are the total open charges for Omni-Protech Drugs Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Omni-Protech Drugs Private Limited amount to ₹ 31.65 Cr.

  • When was the last Balance Sheet of Omni-Protech Drugs Private Limited filed with the ROC?

    The most recent Balance Sheet for Omni-Protech Drugs Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development